Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)

NCT03392545 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT03392545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
April 1, 2018
Completion date
June 1, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioma of brainstem, glioma, malignant, high grade glioma